NeuroIntact Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

NeuroIntact General Information

Description

Manufacturer of a brain-cooling medical device intended for patients suffering from traumatic brain injury, stroke, or elevated intracranial pressure. The company's platform develops a targeted temperature management system that enables non-invasive intranasal cooling of the brain to reduce swelling and manage core temperature without systemic side-effects, enabling hospitals and critical-care providers to offer neuroprotection and improved outcomes in neurological emergencies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1100 Wicomico Street
  • Suite 330
  • Baltimore, MD 21230
  • United States
+1 (717)
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • 1100 Wicomico Street
  • Suite 330
  • Baltimore, MD 21230
  • United States
+1 (717)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroIntact Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Aug-2025 Completed Generating Revenue
1. Angel (individual) 01-Jun-2024 Completed Generating Revenue
To view NeuroIntact’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NeuroIntact Patents

NeuroIntact Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025265909-A1 Nasal cannula temperature control Pending 01-May-2024
US-20250339310-A1 Nasal cannula temperature control Pending 01-May-2024
WO-2025230829-A1 Nasal cannula temperature control Pending 01-May-2024
US-20250339309-A1 Sensor-based nasal cannula temperature control Pending 01-May-2024
US-20250339311-A1 Temperature regulated fluid therapy Pending 01-May-2024 A61F7/12
To view NeuroIntact’s complete patent history, request access »

NeuroIntact Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroIntact Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Neuvation Ventures Venture Capital Minority
Central Texas Angel Network Angel Group Minority
Riptide Ventures Angel Group Minority
To view NeuroIntact’s complete investors history, request access »

NeuroIntact FAQs

  • When was NeuroIntact founded?

    NeuroIntact was founded in 2016.

  • Where is NeuroIntact headquartered?

    NeuroIntact is headquartered in Baltimore, MD.

  • What is the size of NeuroIntact?

    NeuroIntact has 7 total employees.

  • What industry is NeuroIntact in?

    NeuroIntact’s primary industry is Therapeutic Devices.

  • Is NeuroIntact a private or public company?

    NeuroIntact is a Private company.

  • What is NeuroIntact’s current revenue?

    The current revenue for NeuroIntact is .

  • Who are NeuroIntact’s investors?

    Neuvation Ventures, Central Texas Angel Network, and Riptide Ventures have invested in NeuroIntact.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process